BR0109917A - Método de administração oral e composição para medicamentos sólidos ou suplementos dietéticos - Google Patents

Método de administração oral e composição para medicamentos sólidos ou suplementos dietéticos

Info

Publication number
BR0109917A
BR0109917A BR0109917-5A BR0109917A BR0109917A BR 0109917 A BR0109917 A BR 0109917A BR 0109917 A BR0109917 A BR 0109917A BR 0109917 A BR0109917 A BR 0109917A
Authority
BR
Brazil
Prior art keywords
oral delivery
delivery composition
composition
solid object
oral administration
Prior art date
Application number
BR0109917-5A
Other languages
English (en)
Inventor
Richard Fuisz
Original Assignee
Richard Fuisz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richard Fuisz filed Critical Richard Fuisz
Publication of BR0109917A publication Critical patent/BR0109917A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"MéTODO DE ADMINISTRAçãO ORAL E COMPOSIçãO PARA MEDICAMENTOS SóLIDOS OU SUPLEMENTOS DIETéTICOS". Trata-se de uma composição de liberação oral e processo são providos para facilitação de intumescimento de um objeto sólido tal como uma pílula, tablete, cápsula ou caplet. A composição de liberação oral é constituída por uma mistura de um líquido base e pelo menos um aditivo. O aditivo é selecionado e está presente na composição de liberação oral em uma concentração suficiente de modo que a composição de liberação oral tem propriedades físicas aperfeiçoadas, em comparação com o líquido base, de modo que quando a composição de liberação oral e um objeto sólido a ser intumescido por um usuário são administrados juntos para o usuário e intumescidos, o objeto sólido é menos provável de tornar-se alojado ou colado sobre superfícies da língua, garganta, palato ou esofageal do usuário, em comparação a quando o líquido base e o objeto sólido são administrados juntos e intumescidos.
BR0109917-5A 2000-04-05 2001-04-05 Método de administração oral e composição para medicamentos sólidos ou suplementos dietéticos BR0109917A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19459200P 2000-04-05 2000-04-05
US09/672,949 US6337083B1 (en) 2000-04-05 2000-09-29 Oral delivery method and composition for solid medications or dietary supplements
PCT/US2001/010989 WO2001076634A1 (en) 2000-04-05 2001-04-05 Oral delivery method and composition for solid medications or dietary supplements

Publications (1)

Publication Number Publication Date
BR0109917A true BR0109917A (pt) 2003-08-05

Family

ID=26890190

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109917-5A BR0109917A (pt) 2000-04-05 2001-04-05 Método de administração oral e composição para medicamentos sólidos ou suplementos dietéticos

Country Status (11)

Country Link
US (1) US6337083B1 (pt)
EP (1) EP1385552B1 (pt)
JP (1) JP2003530359A (pt)
CN (1) CN1431916A (pt)
AT (1) ATE364401T1 (pt)
AU (2) AU4986001A (pt)
BR (1) BR0109917A (pt)
CA (1) CA2404641C (pt)
DE (1) DE60128966T2 (pt)
MX (1) MXPA02009945A (pt)
WO (1) WO2001076634A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39125E1 (en) 2000-03-13 2006-06-13 Ryukakusan Co. Ltd Swallowing-assistive drink
KR101179541B1 (ko) * 2003-04-25 2012-09-05 레킷트 벵키저 헬스케어(유케이)리미티드 증점성 조성물
US20050208108A1 (en) * 2004-03-19 2005-09-22 Jannusch Leonard C Thermoplastic films and methods for making
GB2430364A (en) * 2005-09-22 2007-03-28 Carl Ernest Alexander Soft agar bolus for oral drug delivery
US8187659B2 (en) * 2006-05-02 2012-05-29 Jerry Robertson Real Estate Llc Solid medicament dosage form consumption aid
US8383135B2 (en) 2010-12-03 2013-02-26 Richard C. Fuisz Solid dosage form that promotes reliable oral, esophageal and GI transit
US9452135B2 (en) 2012-03-20 2016-09-27 Particle Dynamics International, Llc Gelling agent-based dosage form
FR3001153B1 (fr) 2013-01-21 2015-08-21 Eredova Produit d'assistance a l'ingestion d'un compose solide
US11234897B2 (en) 2017-03-27 2022-02-01 DXM Pharmaceutical, Inc. Packaged multi-dose liquid dextromethorphan hydrobromide formulation
IT201800001301A1 (it) * 2018-01-18 2019-07-18 Univ Degli Studi Di Camerino Formulazioni in gel per la somministrazione orale di farmaci, in particolare nei pazienti disfagici

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ94394A3 (en) * 1991-10-28 1994-12-15 Procter & Gamble Beverage system thickener/emulsifying agent and process for preparing a beverage with such system
JPH05139958A (ja) * 1991-11-26 1993-06-08 Freunt Ind Co Ltd 易嚥下性医薬品
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
JPH0826976A (ja) * 1994-07-21 1996-01-30 Freunt Ind Co Ltd 食品状医薬品
JP4309481B2 (ja) * 1996-01-12 2009-08-05 テイコクメディックス株式会社 ゼリー状経口医薬組成物
US5643204A (en) * 1996-03-15 1997-07-01 Cover; Charles L. Pill swallowing device and method
EP0918513B1 (de) * 1996-08-15 2000-12-06 Losan Pharma GmbH Gut schluckbare orale arzneiform
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
JP3257983B2 (ja) * 1997-07-31 2002-02-18 株式会社龍角散 薬剤の嚥下補助飲料
JP3798913B2 (ja) * 1998-07-31 2006-07-19 伊那食品工業株式会社 増粘用添加液
JP4248653B2 (ja) * 1998-12-28 2009-04-02 ライオン株式会社 易嚥下補助組成物並びにこれを用いた食品用組成物及び医薬品用組成物
WO2000044242A1 (fr) * 1999-01-28 2000-08-03 Dainippon Pharmaceutical Co., Ltd. Denrees alimentaires facilitant l'ingestion et/ou la deglutition et procede de production

Also Published As

Publication number Publication date
EP1385552A1 (en) 2004-02-04
EP1385552B1 (en) 2007-06-13
MXPA02009945A (es) 2004-08-19
CA2404641A1 (en) 2001-10-18
JP2003530359A (ja) 2003-10-14
ATE364401T1 (de) 2007-07-15
AU2001249860B2 (en) 2005-12-01
DE60128966D1 (de) 2007-07-26
WO2001076634A1 (en) 2001-10-18
DE60128966T2 (de) 2008-02-28
EP1385552A4 (en) 2005-08-10
AU4986001A (en) 2001-10-23
US6337083B1 (en) 2002-01-08
CA2404641C (en) 2010-10-26
CN1431916A (zh) 2003-07-23

Similar Documents

Publication Publication Date Title
US6406717B2 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
ES2302926T5 (es) Cápsula blanda masticable
US6589555B2 (en) Effervescent vitaceutical compositions and related methods
ES2233329T3 (es) Comprimidos que se desintegran rapidamente en la cavidad bucal.
CN100571784C (zh) 咀嚼产品
US20090169682A1 (en) Functional Masticatory Material, Method Of Producing The Same And Method Of Using The Same
ATE173159T1 (de) Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
EA200200840A1 (ru) Устойчивые к порче композиции опиоидных агонистов для перорального введения
US9452135B2 (en) Gelling agent-based dosage form
BR0109917A (pt) Método de administração oral e composição para medicamentos sólidos ou suplementos dietéticos
KR101790666B1 (ko) 애완동물용 구강용해필름
HUP0400127A2 (hu) Paracetamolt tartalmazó lenyelhető tabletta
JP2001010977A (ja) 経口用組成物
US20050088632A1 (en) Vitasolve dissolving film strips with supplements pharmaceutical drug(RX), +vitamins
AR043370A1 (es) Composiciones farmaceuticas de administracion oral y metodos para evitar la interaccion alimento -droga
JP2021105057A (ja) 固形製剤
Levine et al. Esophageal stricture caused by a Motrin tablet (ibuprofen)
Almajidi et al. An overview on oroslippery technique as a promising alternative for tablets used in Dysphagia
Lee et al. Various upper endoscopic findings of acute esophageal thermal injury induced by diverse food: a case series
Abramson et al. Corrosive injury of the oral cavity and esophagus caused by some denture cleanser powders
Stenson et al. Ingestion of caustic cosmetic products
CN101296687A (zh) 用于系统性药物的口服载体
Pandey et al. Orodispersible Tablets–A Review
JP2006206465A (ja) 持続性口腔内溶解用固形製剤
US4446132A (en) Nontoxic aspirin composition

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]